The home infusion therapy devices market size was valued at USD 18.3 million in 2020 and is anticipated to reach USD 41.4 million by 2028, expanding at a CAGR of 10.2% during the forecast period, 2021 – 2028.
Infusion therapy is a common technique of pain relief, particularly for conditions when oral medicine is ineffective. Infusion treatment is commonly used for gastrointestinal illnesses, diabetes, and cancer-related discomfort. Infusion therapy is also beneficial in the treatment of diseases including cystic fibrosis and persistent dehydration. Infusion therapy at home reduces the number of hospital visits and increases medication adherence. Needleless connectors, infusion pumps, and intravenous sets are some of the most regularly used infusion devices for medicine administration.
The pandemic of COVID-19 had a beneficial impact on the home infusion market since the technique of home infusion was the need of the hour as healthcare facilities were overburdened with COVID patients. The regional and national lockdowns had a substantial impact on operations and supply chains. Several people were hospitalised as a result of the COVID-19 pandemic, and several of them had to be put on ventilators.
Market Drivers, Restraints, and Opportunities:
- Need for home infusion therapy is growing in response to rising infusion device demand and rising healthcare spending around the world.
- Continuous improvements in home infusion therapy, such as the availability and capabilities of care workers, professional education, transparency about the quality of care, and remote patient management are estimated to fuel the market.
- Factors such as rapid technological advancements in intravenous equipment, as well as favourable government regulations for older individuals, are projected to propel the market.
- Increased prevalence of chronic diseases like as cardiovascular, orthopaedic, diabetes, and cancer is expected to propel the market.
- Lack of acceptance of advanced surgical instruments is estimated to hinder the market growth.
- Deficiency of funding is projected to hamper the market growth.
- Despite the inherent safety benefits and long-term cost savings of home infusion therapy, patients are unable to afford it due to insufficient reimbursement, this is anticipated to restrain the market.
- Product recalls and a convoluted reimbursement mechanism are two big roadblocks for the market expansion.
Scope of the report:
The report on the home infusion therapy devices market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Attributes
|
Details
|
Report Title
|
Home Infusion Therapy Devices Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2020
|
Historic Data
|
2018-2019
|
Forecast Period
|
2021-2028
|
Segmentation
|
Products (Intravenous Sets, Infusion Pumps, Needleless Connectors, and IV Cannulas), Applications (Anti-infective, Hydration Therapy, Endocrinology, Enteral Nutrition, Chemotherapy, Specialty Pharmaceuticals, Parenteral Nutrition, and Others)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players covered in the Report
|
Caesarea Medical Electronics, Becton, Dickinson and Co., Baxter, B. Braun Medical Inc., ICU Medical Inc., Fresenius SE & Co. KGaA.
|
The Home Infusion Therapy Devices Market Segment Insights:
The infusion pumps segment held the majority of the market share.
Based on products, the market is segregated into intravenous sets, infusion pumps, needleless connectors, and iv cannulas. The infusion pumps segment accounted for the major revenue share of in 2020, because these pumps are commonly favored for the administration of nutrition and medications. The segment's growth is aided by the availability of a wide range of products, including enteral, syringe, multichannel, and peristaltic pumps. Smart pumps are becoming increasingly popular because they have modern features such as barcode technology, which aids in the authentication of a patient's identity and prevents drug administration problems.
The anti-infective segment is projected to expand at a high CAGR
On the basis of applications, the market is fragmented into anti-infective, hydration therapy, endocrinology, enteral nutrition, chemotherapy, specialty pharmaceuticals, parenteral nutrition, and others. The anti-infective segment is projected to expand at a high CAGR during the forecast period. This is due to the large number of procedures involved in administering antifungal and antibiotic medications. It also aids in the reduction of patient exposure to other hospital-acquired infections (HAIs).
The chemotherapy segment is expected to be the rapid-growing segment during the projected period. The need for pressure pumps is likely to rise in the coming years as the number of cancer cases rises. Chemotherapy pumps for home usage are small, continuous-pressure pumps that do not require a battery and are used for longer period of time. Chemotherapy medications can be supplied at the optimum infusion pace and in the precise doses with the help of these pumps.
North America is expected to dominate the market.
In terms of regions, the home infusion therapy devices market is classified as North America, Europe, Latin America, Asia Pacific, and Middle East and Africa. North America dominates the global market. Demand for home infusion therapy devices is being driven by the growing popularity of non-hospital operations and the large number of geriatric patients who require infusion therapies on a regular basis.
Segments
By Product
- Intravenous Sets
- Infusion Pumps
- Needleless Connectors
- IV Cannulas
By Application
- Anti-Infective
- Hydration Therapy
- Endocrinology
- Enteral Nutrition
- Chemotherapy
- Specialty Pharmaceuticals
- Parenteral Nutrition
- Others
By Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
By Key Players
- Caesarea Medical Electronics
- Becton
- Dickinson and Co
- Baxter
- B. Braun Medical Inc
- ICU Medical Inc
- Fresenius SE & Co
- KGaA.
Competitive Landscape
Major players in the market include Caesarea Medical Electronics, Becton, Dickinson and Co., Baxter, B. Braun Medical Inc., ICU Medical Inc., Fresenius SE & Co. KGaA. Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.